October 31, 2023
Olympus Corporation
Terumo Corporation

Olympus and Terumo Announce Change in Form of Contract
From a comprehensive partnership agreement to individual project agreements

Olympus Corporation (Olympus) and Terumo Corporation (Terumo) have agreed to change
their “Comprehensive partnership agreement covering the development of medicalequipment,” established in 2005, to individual contracts for single projects.
The two companies entered the comprehensive partnership agreement in 2005 with themain objectives of strengthening the relationship through a capital partnership andstrengthening the framework for promoting collaboration. As part of this agreement,
Olympus and Terumo have developed “VisiGlide”, a disposable guidewire for endoscopic
treatment of the pancreas and bile ducts in the gastrointestinal field, and “Virtuosaph” forendoscopic vein harvesting*1 in the cardiovascular surgical field and have marketed bothproducts through Olympus and Terumo sales channels. In addition to product development,
Olympus and Terumo mutually utilized their management resources through capital
partnerships and personnel exchanges.
In 2017, both companies decided that a good cooperative relationship could continue
without a capital relationship and terminated the capital partnership.
In light of these considerations, both companies agreed that the objectives under thecomprehensive partnership agreement have been achieved and will continue cooperating in
product development and sales under individual contracts.
Moving forward, Olympus and Terumo will continue to strive to improve the world's medicalstandards by leveraging their strengths and good cooperative relationships to continue
providing medical devices to the global market.
*1 A small hole is pierced in the leg, and an endoscope is inserted to detach and remove theblood vessels.

-1-About Olympus
At Olympus, we are committed to Our Purpose of making people’s lives healthier, safer andmore fulfilling. As a global medical technology company, we partner with healthcare
professionals to provide best-in-class solutions and services for early detection, diagnosis
and minimally invasive treatment, aiming to improve patient outcomes by elevating thestandard of care in targeted disease states.
For more than 100 years, Olympus has pursued a goal of contributing to society by
producing products designed with the purpose of delivering optimal outcomes for its
customers around the world.

About Terumo
Terumo is a global leader in medical technology and has been committed to "Contributing toSociety through Healthcare" for 100 years. Based in Tokyo and operating globally, Terumo
employs more than 30,000 associates worldwide to provide innovative medical solutions inmore than 160 countries and regions.
The company started as a Japanese thermometer manufacturer and has been supporting
healthcare ever since. Now, its extensive business portfolio ranges from vascularintervention and cardio-surgical solutions, blood transfusion and cell therapy technology, tomedical products essential for daily clinical practice such as transfusion systems, diabetescare, and peritoneal dialysis treatments.
Terumo will further strive to be of value to patients, medical professionals, and society atlarge.

-2-